US2015036104A1PendingUtilityA1

Method and Apparatus for Testing for Color Vision Loss

Individually held — no corporate assignee on recordPriority: May 3, 2012Filed: Mar 24, 2014Published: Feb 5, 2015
Est. expiryMay 3, 2032(~5.8 yrs left)· nominal 20-yr term from priority
A61B 3/022A61B 3/0041A61B 3/0025A61B 3/066
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method and apparatus for administering eye tests to identify cone sensitivity loss associated with hereditary and acquired color vision loss which may be used for early detection, progress, treatment, and monitoring of eye conditions, traumatic brain injury, optic neuritis, systemic and neurological diseases including Glaucoma, Retinopathy, Age-Related Macular Degeneration, Multiple Sclerosis, Alzheimer's Disease, and Parkinson's Disease and retinal toxicity. Particularly, the method and apparatus disclosed uses a Cone Contrast Test (CCT) to test individuals for hereditary or acquired color vision loss associated with (a) early signs of potential disease/damage/toxicity in an effort to (i) provide opportunity for treatment, and (ii) prevent permanent eye damage, and (b) monitor progress and treatment of such disease/damage/toxicity. The system comprises a computer system including an input device and a display device, and the accuracy and repeatability of the testing is provided by repeated calibration using a colormeter.

Claims

exact text as granted — not AI-modified
1 . A computerized method for administering a cone contrast (CCT) color vision test to a patient, comprising the steps of:
 (a) displaying a first character in a first color at a first contrast level on a display driven by said computer;   (b) receiving a first input signal from said patient via an input device connected to said computer, where said input signal is indicative of whether said patient recognizes said first character displayed in said first color at said first contrast level;   (c) displaying a second character in said first color at a second contrast level on said display driven by said computer;   (d) receiving a second input signal from said patient via an input device connected to said computer, where said input signal is indicative of whether said patient recognizes said second character displayed in said first color at said second contrast level;   (e) assigning a score to said first and second input signals, said score related to sensitivity of a cone in said patient's eye to said first color at said first and second contrast levels; and,   (f) storing said score in a storage device to track said cone sensitivity over time.   
     
     
         2 . The computerized method for detecting color vision loss in a patient recited in  claim 1 , wherein said second contrast level is lower than said first contrast level. 
     
     
         3 . The computerized method for detecting color vision loss in a patient recited in  claim 1 , further comprising the step of displaying said score on a computer display. 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . The computerized method for administering a color vision test in a patient recited in  claim 1 , further comprising the steps of periodically verifying a calibration of said first color and said first contrast level of said first character to be displayed on said display, where said verifying is accomplished by software and, if necessary, preventing other software applications from interfering with said calibration. 
     
     
         7 . The computerized method for detecting color vision loss in a patient recited in  claim 6 , wherein the step of verifying a calibration is automatic if said calibration fails. 
     
     
         8 . (canceled) 
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . (canceled) 
     
     
         12 . (canceled) 
     
     
         13 . (canceled) 
     
     
         14 . (canceled) 
     
     
         15 . (canceled) 
     
     
         16 . (canceled) 
     
     
         17 . (canceled) 
     
     
         18 . (canceled) 
     
     
         19 . (canceled) 
     
     
         20 . (canceled) 
     
     
         21 . (canceled) 
     
     
         22 . (canceled) 
     
     
         23 . (canceled) 
     
     
         24 . (canceled) 
     
     
         25 . (canceled) 
     
     
         26 . (canceled) 
     
     
         27 . (canceled) 
     
     
         28 . (canceled) 
     
     
         29 . (canceled) 
     
     
         30 . (canceled) 
     
     
         31 . (canceled) 
     
     
         32 . (canceled) 
     
     
         33 . (canceled) 
     
     
         34 . (canceled) 
     
     
         35 . (canceled) 
     
     
         36 . (canceled) 
     
     
         37 . (canceled) 
     
     
         38 . (canceled) 
     
     
         39 . (canceled) 
     
     
         40 . (canceled) 
     
     
         41 . (canceled) 
     
     
         42 . (canceled) 
     
     
         43 . (canceled) 
     
     
         44 . (canceled) 
     
     
         45 . (canceled) 
     
     
         46 . (canceled)

Join the waitlist — get patent alerts

Track US2015036104A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.